The results presented in Figs 2 and 3 plus our previously published data suggest that UBXN2A may have a broad tumor suppressive role in colon cancer cells that extends beyond its direct initiation of apoptotic mechanisms (Sane et al., 2014) and targets the mot‐2‐dependent EMT properties of colon cancer cells. This evidence concerns the gene HSPA9 and colonic neoplasm.